Details of Pine Bark Extract
Latin Name: Pinus massoniana L.
Part Used: Bark
Source of Plant: China
Active Ingredients: Proanthocyanidins (monomers, oligomers, polymers)
Sources of Pine Park Extract
Pine Bark OPCs help Vitamin C to work better in the brain to effectively synthesize the neurotransmitters norepinephirine, dopamine and serotonin. Also it protect against free-radical damage, suggested to be a major cause of the ageing process. It may effective for slowing retinopathy, the gradual break down of the retina in the eyes.
Ingredients of Pine Park Extract
Pine Bark OPCs help Vitamin C to work better in the brain to effectively synthesize the neurotransmitters norepinephirine, dopamine and serotonin. Also it protect against free-radical damage, suggested to be a major cause of the ageing process. It may effective for slowing retinopathy, the gradual break down of the retina in the eyes.
Specification of Pine Park Extract
| Item | SPECIFICATION |
| Description: | |
| Appearance | Reddish brown fine powder |
| Flavor & Odor | Characteristic |
| Particle size | 100% pass 80 mesh |
| Physical: | |
| Loss on Drying | ≤5.0% |
| Bulk density | 40-60g/100ml |
| Sulphated Ash | ≤5.0% |
| GMO | Free |
| General Status | Non-irradiated |
| Chemical: | |
| Pb | ≤3mg/kg |
| As | ≤1mg/kg |
| Hg | ≤0.1mg/kg |
| Cd | ≤1mg/kg |
| Assay: | |
| Proanthocyanidin | ≥95% UV |
| Microbial: | |
| Total microbacterial count | ≤1000cfu/g |
| Yeast & Mold | ≤100cfu/g |
| E.Coli | Negative |
| Staphylococcus aureus | Negative |
| Salmonella | Negative |
| Enterobacteriaceaes | Negative |
Study of Pine Park Extract
(1) Steadying vascular wall, inhibiting inflammation.
(2) Eliminating free radicals, preventing arteriosclerosis.
(3) Protecting the skin from injury by superfluous ultraviolet radiation and free radicals.
(4) Resisting cancer, inflammation and allergen
Reference of Pine Park Extract
1. Rohdewald, P (2002). "A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology". International journal of clinical pharmacology and therapeutics 40 (4): 158–68.
2. Hidaka, Takayuki; Nakamura, Shuji; Umemura, Takashi; Jitsuiki, Daisuke; Soga, Junko; Goto, Chikara; Chayama, Kazuaki; Yoshizumi, Masao (2007). "Pycnogenol, French Maritime Pine Bark Extract, Augments Endothelium-Dependent Vasodilation in Humans". Hypertension Research 30 (9): 775–80.
3. Liu, Ximing; Zhou, Ha-Jun; Rohdewald, Peter (2004). "French Maritime Pine Bark Extract Pycnogenol Dose-Dependently Lowers Glucose in Type 2 Diabetic Patients". Diabetes Care 27 (3): 839.
4. Schäfer, Angelika; Högger, Petra (2007). "Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit α-glucosidase". Diabetes Research and Clinical Practice 77 (1): 41–6.